Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Cancer Chemotherapy and Pharmacology|March 1, 2015
Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further studyYogesh T Patel, Megan O Jacus, Nidal Boulos, et al.
Pediatric Blood & Cancer|April 22, 2011
Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumorsLisa M McGregor, Clinton F Stewart, Kristine R Crews, et al.
Scientific Reports|September 1, 2023
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcomaJin-Ah Kim, Kenneth A Crawford, Piero A Spada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemiaKristine R Crews, Varsha Gandhi, Deo Kumar Srivastava, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumoursSara M Federico, Kenneth J Caldwell, Mary B McCarville, et al.
Journal of Neuro-Oncology|October 4, 2005
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in childrenAlberto Broniscer, Murali Chintagumpala, Maryam Fouladi, et al.
Investigational New Drugs|July 29, 2011
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastomaWayne L Furman, Lisa M McGregor, M Beth McCarville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium reportAlberto Broniscer, Sridharan Gururangan, Tobey J MacDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium reportMaryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report, Maryam Fouladi, Wayne L Furman, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|March 1, 2015
Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further studyYogesh T Patel, Megan O Jacus, Nidal Boulos, et al.
Pediatric Blood & Cancer|April 22, 2011
Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumorsLisa M McGregor, Clinton F Stewart, Kristine R Crews, et al.
Scientific Reports|September 1, 2023
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcomaJin-Ah Kim, Kenneth A Crawford, Piero A Spada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemiaKristine R Crews, Varsha Gandhi, Deo Kumar Srivastava, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumoursSara M Federico, Kenneth J Caldwell, Mary B McCarville, et al.
Journal of Neuro-Oncology|October 4, 2005
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in childrenAlberto Broniscer, Murali Chintagumpala, Maryam Fouladi, et al.
Investigational New Drugs|July 29, 2011
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastomaWayne L Furman, Lisa M McGregor, M Beth McCarville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium reportAlberto Broniscer, Sridharan Gururangan, Tobey J MacDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium reportMaryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report, Maryam Fouladi, Wayne L Furman, et al.
Pageof 22